These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 958891

  • 1. [Letter: Effect of bromocryptine on the fluctuations following dopa therapy. On-off phenomenon in parkinsonian patients].
    Frattola L, Albizzati MG, Spano PF, Trabucchi M.
    Nouv Presse Med; ; 5(28):1761. PubMed ID: 958891
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Low CSF GABA in Parkinsonian patients who respond poorly to therapy or suffer from the "on-off" phenomenon.
    Teychenné PF, Ziegler MG, Lake CR, Enna SJ.
    Ann Neurol; 1982 Jan; 11(1):76-9. PubMed ID: 6120678
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bromocriptine and lisuride in Parkinson disease.
    Lieberman AN, Gopinathan G, Neophytides A, Leibowitz M, Walker R, Hiesiger E.
    Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
    [Abstract] [Full Text] [Related]

  • 6. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
    Gawel M, Riopelle R, Libman I, Bouchard S.
    Adv Neurol; 1987 Jan; 45():535-8. PubMed ID: 3548263
    [No Abstract] [Full Text] [Related]

  • 7. [Bromocriptine in Parkinsonian syndromes. Results obtained in a group of patients treated for 8 months].
    Quattrini A, Paggi A, Del Pesce M, Di Bella P.
    Riv Patol Nerv Ment; 1978 Jan; 99(3):150-63. PubMed ID: 752907
    [Abstract] [Full Text] [Related]

  • 8. A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.
    Libman I, Gawel MJ, Riopelle RJ, Bouchard S.
    Can J Neurol Sci; 1987 Nov; 14(4):576-80. PubMed ID: 3319120
    [Abstract] [Full Text] [Related]

  • 9. A comparative study of bromocriptine and levodopa in Parkinson's disease.
    Duvoisin RC, Mendoza MM, Yahr MD.
    Adv Biochem Psychopharmacol; 1980 Nov; 23():271-5. PubMed ID: 7395618
    [No Abstract] [Full Text] [Related]

  • 10. [Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism].
    Kissel P, Andre JM, Jacquier A.
    Nouv Presse Med; 1976 Jan 24; 5(4):210. PubMed ID: 1264671
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of parkinsonian syndromes by bromocriptin].
    Gautier JC, Durand JP.
    Nouv Presse Med; 1977 Jan 22; 6(3):171-4. PubMed ID: 319421
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of Parkinson's disease with bromocriptine].
    Castaigne P, Laplane D, Bousser MG, Bories F.
    Nouv Presse Med; 1976 Apr 23; 6(17):1482. PubMed ID: 1037400
    [No Abstract] [Full Text] [Related]

  • 18. [Oral lisuride in Parkinson's disease].
    Obeso JA, Luquin MR, Martínez Lage JM.
    Med Clin (Barc); 1985 Sep 21; 85(8):307-12. PubMed ID: 4068822
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Letter: Bromocriptine in parkinsonism.
    Debono AG, Donaldson I, Marsden CD, Parkes JD.
    Lancet; 1975 Nov 15; 2(7942):987-8. PubMed ID: 53479
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.